Mobile

Revaccination of healthy non-pregnantwomen with a second dose of a vaccine to asess its safety and the protection it gives from blood poisoning caused by a bacterium

Mise à jour : Il y a 5 ans
Référence : EUCTR2015-003094-15

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Immunogenicity Objective To evaluate the immunogenicity of a second dose of GBS Trivalent Vaccine (5 μg without adjuvant) administered approximately 4-6 years after the initial GBS vaccination, measured by ELISA. Safety Objective To assess the safety and tolerability of a second dose of GBS Trivalent Vaccine (5 μg without adjuvant) administered approximately 4-6 years after the initial dose.

Critère d'inclusion

  • Healthy person immune response to a second dose of Group B Streptococcus
  • polysaccharide capsule antigens

Liens